Senator Marianne Binder-Keller to Become Vice President of the Swiss Cancer Institute
With Marianne Binder-Keller, the Swiss Cancer Institute gains an experienced and well-connected voice from the political arena. She brings a new perspective to the presidency and strengthens the Swiss Cancer Institute’s position at the intersection of cancer research, care, and policy.
Prof. Dr. med. Sacha Rothschild will remain vice president for another three years. With his proven expertise in medical oncology, his clinical expertise will continue to be a central component of the Swiss Cancer Institute’s leadership.
Continuity and New Momentum
The Swiss Cancer Institute extends its warmest congratulations to Marianne Binder-Keller on her election and to Sacha Rothschild on his reelection. Together with President Viviane Hess, the Executive Committee will continue to strengthen its collaboration with policymakers, government agencies, and partners starting in 2027.
As a member of the Executive Board, Marianne Binder-Keller intends to focus her efforts in particular on the political framework for clinical cancer research: “Important projects are on the horizon, such as the implementation of the Cancer Plan and the revision of the Human Research Act. If Switzerland wants to remain a major player in academic clinical cancer research, there needs to be a shake-up in political circles in Bern right now. That’s where I want to make my contribution.”